167 related articles for article (PubMed ID: 19337408)
1. Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
Kripp M; Hofheinz RD
Int J Nanomedicine; 2008; 3(4):397-401. PubMed ID: 19337408
[TBL] [Abstract][Full Text] [Related]
2. Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.
Benesch M; Urban C
Expert Opin Pharmacother; 2008 Feb; 9(2):301-9. PubMed ID: 18201152
[TBL] [Abstract][Full Text] [Related]
3. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
[No Abstract] [Full Text] [Related]
6. Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine.
Prescrire Int; 2006 Feb; 15(81):11-2. PubMed ID: 16548098
[TBL] [Abstract][Full Text] [Related]
7. New liposomal cytarabine formulation in CSF.
Casado P; Torreira C; Oujo E; Esteban P; Albo C; Diaz R; Andrade MA
Clin Lab; 2010; 56(1-2):69-70. PubMed ID: 20380362
[No Abstract] [Full Text] [Related]
8. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
[TBL] [Abstract][Full Text] [Related]
9. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
Sancho JM; Deben G; Parker A; Piñana JL; Bolam S; Sánchez-García E; Giménez E; Pascual T; Fernández-Abellán P; Palomera L; Ribera JM
Int J Hematol; 2007 Jul; 86(1):33-6. PubMed ID: 17675264
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
Phuphanich S; Maria B; Braeckman R; Chamberlain M
J Neurooncol; 2007 Jan; 81(2):201-8. PubMed ID: 16941075
[TBL] [Abstract][Full Text] [Related]
11. [Rationale for the use of liposomal cytarabine in meningeal carcinomatosis].
Boiardi A
Tumori; 2007; 93(3):suppl 1-3. PubMed ID: 17679478
[No Abstract] [Full Text] [Related]
12. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
[TBL] [Abstract][Full Text] [Related]
13. Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases.
Sancho JM; Ribera JM; Romero MJ; Martín-Reina V; Giraldo P; Ruiz E
Haematologica; 2006 Mar; 91(3):ECR02. PubMed ID: 16533729
[TBL] [Abstract][Full Text] [Related]
14. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.
Spina M; Chimienti E; Martellotta F; Vaccher E; Berretta M; Zanet E; Lleshi A; Canzonieri V; Bulian P; Tirelli U
Cancer; 2010 Mar; 116(6):1495-501. PubMed ID: 20108270
[TBL] [Abstract][Full Text] [Related]
16. [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].
Pace A
Tumori; 2007; 93(3):suppl 9-12. PubMed ID: 17679481
[No Abstract] [Full Text] [Related]
17. [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].
Silvani A
Tumori; 2007; 93(3):suppl 6-8. PubMed ID: 17679480
[No Abstract] [Full Text] [Related]
18. [Efficacy of liposomal cytarabine in neoplastic meningitis].
Rudà R; Leoncini B; Laguzzi E; Trevisan E; Guarneri D; Bertetto O; Soffietti R
Tumori; 2007; 93(3):suppl 4-5. PubMed ID: 17679479
[No Abstract] [Full Text] [Related]
19. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
Glantz MJ; LaFollette S; Jaeckle KA; Shapiro W; Swinnen L; Rozental JR; Phuphanich S; Rogers LR; Gutheil JC; Batchelor T; Lyter D; Chamberlain M; Maria BL; Schiffer C; Bashir R; Thomas D; Cowens W; Howell SB
J Clin Oncol; 1999 Oct; 17(10):3110-6. PubMed ID: 10506606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]